| 000 | 01109nab#a2200301#c#4500 | ||
|---|---|---|---|
| 003 | IEF | ||
| 005 | 20190816110633.0 | ||
| 008 | 150409s2015 NLD|| #####0 b|ENG|u | ||
| 040 | _aIEF | ||
| 041 | _aENG | ||
| 100 | 1 |
_aMilewska, Marta _963584 |
|
| 245 |
_aTransfer pricing implications of second - brand strategies in the pharmaceutical industry in light of the OECD report of Action 8 of the BEPS Action Plan _c Marta Milewska and Eliel Amaya _hElectrónico |
||
| 260 | _c2015 | ||
| 500 | _aDisponible únicamente en línea a través de la Biblioteca del IEF. Resumen. | ||
| 650 | 4 |
_aPRECIOS DE TRANSFERENCIA _948095 |
|
| 650 | 4 |
_aGRUPOS DE EMPRESAS _932211 |
|
| 650 | 4 |
_aEMPRESAS FARMACEUTICAS _943550 |
|
| 650 | 4 |
_aEVASION FISCAL _944029 |
|
| 650 | 4 |
_aEROSIÓN DE LA BASE IMPONIBLE Y TRASLADO DE BENEFICIOS _963148 |
|
| 650 | 4 |
_aCONTROL _940745 |
|
| 650 | 4 |
_aMEXICO _947495 |
|
| 650 | 4 |
_943410 _aELUSION FISCAL |
|
| 700 | 1 |
_aAmaya, Eliel _963585 |
|
| 773 | 0 |
_tInternational Transfer Pricing Journal _gv. 22, n. 1, January / February 2015 |
|
| 942 | _cART | ||
| 942 | _z143202 | ||
| 999 |
_c136343 _d136343 |
||